China and South-East Asia accommodate the world's fastest-growing medical and pharmaceutical industries. China as well as many South-East Asian countries like Thailand and Singapore are investing heavily into development of their health-care systems. Key drivers of the market expansion include the rising health care awareness and needs fueled by economic growth, large and aging populations and increasing total per capita health-care spending. As the European SMEs working in pharmaceutical medical will have many opportunities in China and South-East Asia, they also face many IP challenges as counterfeiting are still commonplace in China and South-East Asia. This webinar gave European SMEs an overview of IP protection tools in China and South-East Asia. The experts offered expert tips to draft a comprehensive IP strategy for the medical and pharmaceutical industry in both regions and provided real life case studies involving European SMEs experiencing and overcoming IP issues in medical and pharmaceutical sector.